Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85 | 563 | 8 | 110 | 309 |
| Receivables | 102 | 109 | 99 | 47 | 406 |
| TOTAL | $274 | $763 | $134 | $182 | $752 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 3 | 1 |
| TOTAL | $2 | $2 | $2 | $3 | $1 |
| Total Assets | $276 | $765 | $136 | $184 | $752 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 451 | 650 | 614 | 464 | 711 |
| TOTAL | $451 | $650 | $614 | $464 | $711 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $451 | $650 | $614 | $464 | $711 |
| Shareholders' Equity | |||||
| Common Shares | 21,408 | 21,539 | 21,468 | 21,468 | 21,737 |
| Retained earnings | -26,759 | -26,633 | -26,823 | -26,635 | -26,645 |
| Other shareholders' equity | 404 | 408 | 1,598 | 1,608 | 1,630 |
| TOTAL | $-175 | $115 | $-478 | $-279 | $42 |
| Total Liabilities And Equity | $276 | $765 | $136 | $184 | $752 |